News

Professor Udo Heinemann serves alongside Jens Reich as Ombudsperson for Good Scientific Practice. He was elected by the Scientific Council in September 2019. We spoke with him about rules and misconduct in research and how he perceives his role as an adviser in conflict situations.

Harnessing jumping genes to advance gene-therapy cancer treatment: In an effort to optimize the Sleeping Beauty system, the MDCell – Helmholtz Innovation Lab is extending its collaboration with PlasmidFactory.

At the MDC, a team of three drivers are responsible for getting important people and things from A to B safely and on time. Team coordinator Klaus Billep talks about the important aspects of the job – and reveals that he was already allowed behind the wheel as a young boy.

Cancer develops when DNA defects gradually accumulate over time. Thus, it is considered an age-related disease. But why do children develop tumors? An international team now reveals that rings of DNA can contribute to neuroblastoma in children. The study in Nature Genetics presents the first detailed map of circular DNA.

50 years ago today, on December 10, 1969, a reserved and modest man accepted the Nobel Prize for Medicine in Stockholm. This man was Max Delbrück, a native of Berlin. An article by Detlev Ganten.

An artificial intelligence platform developed at the Max Delbrück Center for Molecular Medicine (MDC) can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process. The deeper analysis shows some colorectal subtypes need to be reclassified.

New lab in Aarhus: The Novo Nordisk Foundation funds MDC scientist Thomas Willnow to the tune of €7 million.

For the first time as neighbours, scientists from BIMSB and HU Berlin came together at a joint symposium. The conference aims to develop scientific exchange and collaborations between the two institutes.

From 1 to 10 November 2019, the Berlin Science Week connected science communities with the public. Researchers from the Max Delbrück Center for Molecular Medicine (MDC) contributed to this international festival at more than ten events. Here are some impressions.

Some 27 young researchers have been selected for the prestigious EMBO Young Investigators Programme. Among this year’s awardees is Philipp Junker, a systems biologist at the MDC’s Berlin Institute for Medical Systems Biology.